- Price
- $223.14
- Day
- +3.69%
- Mkt Cap
- $32.37B
- 52W Range
- $180.27 – $293.81
- Volume
- 1.73M
- Beta
- 0.78
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
BankChampaign National Association acquired a new stake in shares of ResMed Inc. (NYSE: RMD) during the first quarter, according to its most recent filing with the SEC. The fund acquired 2,981 shares of the medical equipment provider's stock, valued at approximately $669,000. Several other institutional investors and hedge funds have also bought and
Read full article
RMD's Q4 results may reflect strong mask and device demand, portfolio innovation, acquisitions and digital health growth, with EPS seen rising 13.7%.
Read full article
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
American Capital Management Inc. cut its stake in ResMed Inc. (NYSE: RMD) by 13.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 265,399 shares of the medical equipment provider's stock after selling 41,557 shares during the period. ResMed
Read full article
Baader Bank Aktiengesellschaft decreased its stake in shares of ResMed Inc. (NYSE: RMD) by 61.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,768 shares of the medical equipment provider's stock after selling 7,696 shares during the quarter. Baader
Read full article
TROY, Mich., July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Broadridge Financial Resources Inc. (NYSE: BR) as its "Stock to Study" and ResMed Inc. (NYSE: RMD) as its "Undervalued Stock" in the October 2026 issue for investors' informational and educational use.
Read full article